96365- Intravenous infusion for therapy, up to 1 hour. J3488– Injection, zoledronic acid (Reclast), 1mg. Physician needs to specify 5 units for approved 5mg dosing of Reclast
What is the CPT code for Reclast?
digits to complete the ICD-10 code for billing M81.0 Age-related Osteoporosis without current fractures M81.8 Other osteoporosis without current fracture M88.___ Paget’s disease M89.9 Disorder of bone, unspecified M94.9 Disorder of cartilage, unspecified
Does Reclast® require hydration prior to administration?
ICD 10 Code: M81.0 Age-related osteoporosis without current pathological fracture ICD 10 Code: M80.0 Age-related osteoporosis with current pathological fracture ICD 10 …
How long does it take to administer Reclast?
A: Reclast® (zoledronic acid) is an infused medication used to treat osteoporosis and Paget’s disease of bone. The appropriate HCPCS Level II supply code for Reclast® is J3489 Injection, zoledronic acid, 1 mg. For an initial infusion of Reclast® lasting 16 minutes or longer, report 96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); …
What is the ICD 10 code for init encntr?
reclast infusion icd 10 code | reclast infusion icd 10 code | icd 10 code for reclast infusion
What is Reclast J code?
Reclast® HCPCS code J3489 (Injection, zoledronic acid 1 mg) should be used to report Reclast®.
What is the ICD 10 code for IV infusion?
Encounter for adjustment and management of infusion pump Z45. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z45. 1 became effective on October 1, 2021.
How do you bill for zoledronic acid infusion?
The appropriate HCPCS Level II supply code for Reclast® is J3489 Injection, zoledronic acid, 1 mg. For an initial infusion of Reclast® lasting 16 minutes or longer, report 96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour.Sep 1, 2017
What is the ICD 10 code for medication management?
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
How do you bill for IV infusion?
CPT Definition:96360: Intravenous Infusion, hydration; initial, 31 minutes to 1 hour.96361: Intravenous Infusion, hydration; each additional hour (list separately in addition to code for primary procedure)
How do you code IV infusions?
Assign CPT 96360- IV hydration, initial 31-90 minutes, and CPT 96361 (add on code), used once infusion lasts 91 minutes in length. An intravenous infusion of hydration of 30 minutes or less is not billable. Hydration infusion must be at least 31 minutes in length to bill the service.Sep 16, 2020
Are Zometa and Reclast the same?
Reclast and Zometa are two different brands of zoledronic acid. Reclast is used to treat or prevent osteoporosis caused by menopause, or steroid use. This medicine also increases bone mass in men with osteoporosis. Reclast is for use when you have a high risk of bone fracture.Mar 17, 2022
Is Reclast infusion covered by Medicare?
Do Medicare prescription drug plans cover Reclast? No. In general, Medicare prescription drug plans (Part D) do not cover this drug.
What is CPT code J3488?
J3488 – Injection, zoledronic acid (reclast), 1 mg.Jan 1, 2014
How do you code for medication management?
The primary billing codes used are:90862 – Defined as pharmacological management including prescription use and review of medication with no more than minimal psychotherapy.90805 – Individual psychotherapy approximately 20 – 30 minutes face to face, with medical evaluation and management services.More items…•Jan 24, 2019
What is ICD-10 code z79899?
899.
What is diagnosis code Z51 81?
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range – Factors influencing health status and contact with health services .
Document Information
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
CMS National Coverage Policy
This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for Bisphosphonates (Intravenous [IV]) and Monoclonal Antibodies in the Treatment of Osteoporosis and Their Other Indications.
Coverage Guidance
This LCD addresses “incident to” drugs that are not self-administered for certain patients with osteoporosis. The other indications for these drugs are also addressed.
General Information
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
CMS National Coverage Policy
CMS Internet-Only Manual, Publication 100-04, Medicare Claims Processing Manual, Chapter 4, §§10.4 and 230.
Article Guidance
Palmetto GBA has received inquiries related to the billing and documentation of infusions, injections and hydration fluids. Documentation, medical necessity, and code assignment are very important.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
What is CMS 1450?
This reimbursement policy applies to services reported using the Health Insurance Claim Form CMS-1500 or its electronic equivalent or its successor form, and services reported using facility claim form CMS-1450 or its electronic equivalent or its successor form. This policy applies to all products, all network and non-network physicians, and other health care professionals.
What is zoledronic acid?
Zoledronic acid (Reclast® and Zometa®) is a bisphosphonic acid, which is an inhibitor of osteoclastic bone resorption. Zoledronic acid binds to the bone matrix, which decreases osteoclastic activity, prevents bone resorption and skeletal calcium release induced by various stimulatory factors released by tumors. Zoledronic acid is currently available under the brand names Zometa ® and Reclast ®.
